Legal Insights

< back to search results

Broad Institute CRISPR-Cas9 patent revoked in Europe

Overview

An article detailing the Opposition Division (OD) of the European Patent Office's (EPO) decision to revoke one of the Broad Institute's foundational CRISPR-Cas9 patents in Europe (EP2771468), upholding the preliminary opinion.